Kuros Biosciences AG: Kuros Biosciences increases 2026 annual guidance, The company reports 40% year-over-year increase in sales in the first nine months of 2026

One daysingle sourceOne outlet reported this, once - no second voice in this corpus.

All 1 reports on Thu, 15 October 2026

What it is about

Drei Jahre Kuros Biosciences Kuros Globenewswire Europe Steigende Anleiherenditen Daniel Geiger Kuros Biosciences Van Dijk Swiss Exchange Meeting Swiss Society Of Spinal Surgery Kuros Biosciences Press Release Bilthoven, Utrecht, Netherlands Georgia, United States Alpharetta, Georgia, United States Switzerland Swiss Netherlands Zurich, ZüSz, Switzerland

Who published it, and when

How it spread - 1 original report

Thu, 15 October 2026
1 report
- finanznachrichten.de07:10first to report
  Kuros Biosciences AG: Kuros Biosciences increases 2026 annual guidance, The company reports 40% year-over-year increase in sales in the first nine months of 2026
  Ad hoc announcement pursuant to Article 53 of the SIX listing rules Kuros Biosciences increases 2026 annual guidanceThe company reports 40% year-over-year increase in sales in the first nine months